The first year of nirsevimab use in Australia for RSV prevention, 2024

Rachel Wilkins; Kerry-Ann O'Grady; Davoud Pourmarzi; Stephen Lambert; Kristine Macartney

The first year of nirsevimab use in Australia for RSV prevention, 2024

Rachel Wilkins
, Kerry-Ann O'Grady
, Davoud Pourmarzi
, Stephen Lambert
, Kristine Macartney

Research output: Contribution to journal › Meeting Abstract › peer-review

Original language	English
Pages (from-to)	S34-S34
Number of pages	1
Journal	Australian and New Zealand Journal of Public Health
Volume	50
Publication status	Published - Feb 2026

Cite this

@article{4822ee13ce6c4651bf081b6d149beae3,

title = "The first year of nirsevimab use in Australia for RSV prevention, 2024",

author = "Rachel Wilkins and Kerry-Ann O'Grady and Davoud Pourmarzi and Stephen Lambert and Kristine Macartney",

year = "2026",

month = feb,

language = "English",

volume = "50",

pages = "S34--S34",

journal = "Australian and New Zealand Journal of Public Health",

issn = "1326-0200",

publisher = "Elsevier B.V.",

}

TY - JOUR

T1 - The first year of nirsevimab use in Australia for RSV prevention, 2024

AU - Wilkins, Rachel

AU - O'Grady, Kerry-Ann

AU - Pourmarzi, Davoud

AU - Lambert, Stephen

AU - Macartney, Kristine

PY - 2026/2

Y1 - 2026/2

UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=anu_research_portal_plus2&SrcAuth=WosAPI&KeyUT=WOS:001798225300074&DestLinkType=FullRecord&DestApp=WOS_CPL

M3 - Meeting Abstract

SN - 1326-0200

VL - 50

SP - S34-S34

JO - Australian and New Zealand Journal of Public Health

JF - Australian and New Zealand Journal of Public Health

ER -

The first year of nirsevimab use in Australia for RSV prevention, 2024

Other files and links

Cite this